Level IV tumor thrombus in non-metastatic renal cell cancer? No, thanks. Level II is better. Lessons learned from a case report

by Galosi, Andrea Benedetto, Papaveri, Alessio, Castellani, Daniele, Agostini, Edoardo, Burattini, Luciano, Dell’Atti, Lucio
Published in Urol Case Rep (2021)

Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder

by Santoni, Matteo, Catanzariti, Francesco, Minardi, Daniele, Burattini, Luciano, Nabissi, Massimo, Muzzonigro, Giovanni, Cascinu, Stefano, Santoni, Giorgio
Published 2012

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma

by Conti, Alessandro, Santoni, Matteo, Amantini, Consuelo, Burattini, Luciano, Berardi, Rossana, Santoni, Giorgio, Cascinu, Stefano, Muzzonigro, Giovanni
Published 2013

Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study

by SANTONI, MATTEO, PACCAPELO, ALESSANDRO, BURATTINI, LUCIANO, BIANCONI, MARISTELLA, CARDINALI, MASSIMO, FABBIETTI, LETIZIA, TRIGNANI, ROBERTO, RYCHLICKI, FRANCO, CASCINU, STEFANO
Published 2012

Seminoma Retroperitoneal Relapse 23 Years After Surgery

by Crocetti, Sonia, Tassone, Laura, Torniai, Mariangela, Pierantoni, Chiara, Burattini, Luciano, Mandolesi, Alessandra, Di Benedetto, Maika, Mantello, Giovanna, Scarpelli, Marina, Berardi, Rossana
Published in Oncol Ther (2021)

Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma

by Piva, Francesco, Giulietti, Matteo, Occhipinti, Giulia, Santoni, Matteo, Massari, Francesco, Sotte, Valeria, Iacovelli, Roberto, Burattini, Luciano, Santini, Daniele, Montironi, Rodolfo, Cascinu, Stefano, Principato, Giovanni
Published in Oncotarget (2015)

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma

by Santoni, Matteo, Scoccianti, Silvia, Lolli, Ivan, Fabrini, Maria Grazia, Silvano, Giovanni, Detti, Beatrice, Perrone, Franco, Savio, Giuseppina, Iacovelli, Roberto, Burattini, Luciano, Berardi, Rossana, Cascinu, Stefano
Published 2013

[(11)C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas

by Santoni, Matteo, Nanni, Cristina, Bittoni, Alessandro, Polonara, Gabriele, Paccapelo, Alessandro, Trignani, Roberto, De Lisa, Mariagrazia, Rychlicki, Franco, Burattini, Luciano, Berardi, Rossana, Fanti, Stefano, Cascinu, Stefano
Published 2014

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma

by Bianconi, Maristella, Faloppi, Luca, Loretelli, Cristian, Zizzi, Antonio, Giampieri, Riccardo, Bittoni, Alessandro, Andrikou, Kalliopi, Prete, Michela Del, Burattini, Luciano, Montironi, Rodolfo, Scartozzi, Mario, Cascinu, Stefano
Published in Oncotarget (2016)

Role of STAT3 pathway in genitourinary tumors

by Santoni, Matteo, Conti, Alessandro, Piva, Francesco, Massari, Francesco, Ciccarese, Chiara, Burattini, Luciano, Cheng, Liang, Lopez-Beltran, Antonio, Scarpelli, Marina, Santini, Daniele, Tortora, Giampaolo, Cascinu, Stefano, Montironi, Rodolfo
Published in Future Sci OA (2015)

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

by Santini, Daniele, Santoni, Matteo, Conti, Alessandro, Procopio, Giuseppe, Verzoni, Elena, Galli, Luca, di Lorenzo, Giuseppe, De Giorgi, Ugo, De Lisi, Delia, Nicodemo, Maurizio, Maruzzo, Marco, Massari, Francesco, Buti, Sebastiano, Altobelli, Emanuela, Biasco, Elisa, Ricotta, Riccardo, Porta, Camillo, Vincenzi, Bruno, Papalia, Rocco, Marchetti, Paolo, Burattini, Luciano, Berardi, Rossana, Muto, Giovanni, Montironi, Rodolfo, Cascinu, Stefano, Tonini, Giuseppe
Published in Oncotarget (2016)